Valan, Bruno
Prakash, Anusha
Ratliff, William
Gao, Michael
Muthya, Srikanth
Thomas, Ajit
Eaton, Jennifer L.
Gardner, Matt
Nichols, Marshall
Revoir, Mike
Tart, Dustin
O’Brien, Cara
Patel, Manesh
Balu, Suresh
Sendak, Mark
Funding for this research was provided by:
National Institutes of Health (R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03, R42 GM144999-03)
Article History
Received: 20 September 2024
Accepted: 22 April 2025
First Online: 11 June 2025
Competing interests
: W.R. reported writing software licensed to Fullsteam Health. M.Gao reported writing software licensed to Clinetic, Cohere Med, and Fullsteam Health. M.Gao reported owning equity in Clinetic. M. Gardner reported writing software licensed to Fullsteam Health. M.N. reported writing software licensed to Clinetic, Cohere Med, and Fullsteam Health. M.N. reported owning equity in Clinetic. M.R. reported writing software licensed to Clinetic, Cohere Med, and Fullsteam Health. M.R. reported owning equity in Clinetic. M.P. reported receiving grants from HeartFlow, Bayer, Janssen, and Novartis outside the submittedwork. S.B. reported writing software licensed to Clinetic, Cohere Med, and Fullsteam Health. SB reported owning equity in Clinetic. M.S. reported writing software licensed to Clinetic, Cohere Med, KelaHealth, and Fullsteam Health. M.S. reported owning equity in Clinetic. M.S. and S.B reported receiving grants from the Gordon and Betty Moore Foundation and the PatrickJ McGovern Foundation. No other disclosures were reported.